Literature DB >> 18463788

The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis.

X Schmit1, J L Vincent.   

Abstract

BACKGROUND: C-reactive protein (CRP) may be a useful marker of sepsis but its use in the evaluation of response to therapy remains poorly defined. The aim of this study was to define the time course of CRP levels in septic patients according to their response to initial antimicrobial treatment, and to search for possible correlations between CRP levels and other clinical and biological variables. PATIENTS AND METHODS: This prospective, observational, multicenter study included all critically ill patients with sepsis admitted to two medico-surgical departments of intensive care in Brussels, Belgium during a 5-month period. CRP levels and standard clinical and biological variables were measured daily from the day of sepsis diagnosis until death, transfer to the general floor, or the seventh day, which ever came first. Patients were divided into three groups according to their clinical course: group 1--patients with a favorable response to initial antibiotic therapy; group 2--patients who required a change in antibiotic therapy; group 3--patients who needed a procedure to control the infection.
RESULTS: CRP concentrations decreased more rapidly and to a greater degree in group 1 than in group 2 patients (p=0.001). An increase in CRP of at least 2.2 mg/dl in the first 48 h was associated with ineffective initial antibiotic therapy with a sensitivity of 77% and a specificity of 67%. No correlation was found between CRP levels and other clinical and biological variables.
CONCLUSION: Changes in CRP levels over the first 48 h of therapy can help to evaluate the response to initial antimicrobial therapy in septic patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18463788     DOI: 10.1007/s15010-007-7077-9

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  33 in total

Review 1.  Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis?

Authors:  Dubravka Kojic; Benedikt H Siegler; Florian Uhle; Christoph Lichtenstern; Peter P Nawroth; Markus A Weigand; Stefan Hofer; Thorsten Brenner
Journal:  World J Exp Med       Date:  2015-05-20

2.  [Severe bacterial infection: increased mortality in elderly women with low body weight taking drugs prolonging the QTc interval].

Authors:  S Suefke; H Djonlagić; T Kibbel
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-04-29       Impact factor: 0.840

Review 3.  Diagnosing sepsis - The role of laboratory medicine.

Authors:  Shu-Ling Fan; Nancy S Miller; John Lee; Daniel G Remick
Journal:  Clin Chim Acta       Date:  2016-07-04       Impact factor: 3.786

4.  Sepsis Biomarkers.

Authors:  Yachana Kataria; Daniel Remick
Journal:  Methods Mol Biol       Date:  2021

Review 5.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

Review 6.  Clinical application of sepsis biomarkers.

Authors:  Vinoth Sankar; Nigel R Webster
Journal:  J Anesth       Date:  2012-10-30       Impact factor: 2.078

Review 7.  [Use of biomarkers in sepsis. Update and perspectives].

Authors:  B H Siegler; S Weiterer; C Lichtenstern; D Stumpp; T Brenner; S Hofer; M A Weigand; F Uhle
Journal:  Anaesthesist       Date:  2014-09       Impact factor: 1.041

Review 8.  Role of biomarkers in sepsis care.

Authors:  Ravi S Samraj; Basilia Zingarelli; Hector R Wong
Journal:  Shock       Date:  2013-11       Impact factor: 3.454

9.  Septic shock and chemotherapy-induced cytopenia: effects on microcirculation.

Authors:  Thomas Karvunidis; Jiri Chvojka; Daniel Lysak; Roman Sykora; Ales Krouzecky; Jaroslav Radej; Ivan Novak; Martin Matejovic
Journal:  Intensive Care Med       Date:  2012-05-15       Impact factor: 17.440

10.  A Systemic Inflammation Mortality Risk Assessment Contingency Table for Severe Sepsis.

Authors:  Joseph A Carcillo; Katherine Sward; E Scott Halstead; Russell Telford; Adria Jimenez-Bacardi; Bita Shakoory; Dennis Simon; Mark Hall
Journal:  Pediatr Crit Care Med       Date:  2017-02       Impact factor: 3.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.